Scaling up cervical cancer screening in the midst of human papillomavirus vaccination advocacy in Thailand

BMC Health Services Research

Volumn 10, Issue SUPPL. 1, 2010, Pages

  Yothasamut, Jomkwan ^a   Putchong, Choenkwan ^a   Sirisamutr, Teera ^a   Teerawattananon, Yot ^a   Tantivess, Sripen ^a  

^a MINISTRY OF PUBLIC HEALTH   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

WART VIRUS VACCINE;

ARTICLE; COST BENEFIT ANALYSIS; EARLY DIAGNOSIS; ECONOMICS; FEMALE; HEALTH CARE POLICY; HUMAN; MASS SCREENING; POLITICS; THAILAND; UTERINE CERVIX TUMOR;

COST-BENEFIT ANALYSIS; EARLY DETECTION OF CANCER; FEMALE; HEALTH POLICY; HUMANS; MASS SCREENING; PAPILLOMAVIRUS VACCINES; POLITICS; THAILAND; UTERINE CERVICAL NEOPLASMS;

EID: 77954346063     PISSN: None     EISSN: 14726963     Source Type: Journal    
DOI: 10.1186/1472-6963-10-S1-S5     Document Type: Article

References (40)

1. Cervical cancer, HPV and HPV vaccines. WHO, Key points for policy makers and health professionals. Geneva 2007
2. A Papillomavirus DNA from a cervical carcinoma and its prevalence in cancer biopsy samples from different geographic regions. M Durst L Gissmann H Ikenberg H zur Hausen, Proc Natl Acad Sci U S A 1983 80 3812 3815 10.1073/pnas.80.12.3812 6304740
3. Controversial new vaccine to prevent cervical cancer. J Parry, Bulletin of the World Health Organization 2006 84 2 86 7 16501722
4. Coverage of cervical cancer screening in 57 countries: Low average levels and large inequalities. E Gakidou S Nordhagen Z Obermeyer, PLoS Med. 2008 5 6 132 10.1371/journal. pmed.0050132 10.1371/journal.pmed.0050132 18563963
5. Cervical cancer: the sub-Saharan Africa perspective. R Anorlu, Reproductive Health Matters 2008 16 32 41 9 10.1016/S0968-8080(08)32415-X 19027621
6. Cervical cancer screening in developing countries. WHO, Report of a WHO consultation 2002
7. The need for public education on HPV and cervical cancer prevention in Asia: Opinions of experts at the AOGIN Conference. S Garland S Park H Ngan I Frazer E Tay, Vaccine 2008 26 5435 40 10.1016/j.vaccine.2008.07.077 18706952
8. Cancer Incidence Trends in Thailand, 1989-2000. H Sriplung S Wiangnon S Sontipong Y Sumitsawan N Martin, Asian Pacific Journal of Cancer Prevention 2006 7 239 44 16839216
9. Cervical cancer screening in Thailand: an overview. S Sriamporn T Khuhaprema M Parkin, J Med Screen 2006 13 Suppl 1 39 S43 17227641
10. VIA and cryotherapy: Doing what's best. B Chumworathayi K Limpaphayom S Srisupundit P Lumbiganon, Journal of the Medical Association of Thailand 2006 89 8 1333 9 17048450
11. Research for the development of an optimal policy strategy for prevention and control of cervical cancer in Thailand. V Tangcharoensathien S Limwattananon R Chaugwon N Praditsitthikorn Y Teerawattananon S Tantivess, Nonthaburi: IHPP and HITAP 2008 http://www.hitap.net/backoffice/report/pdf- reports/2009-01-16-FinalReport-01-301-2550.pdf
12. Cervical cancer prevention and control in views of stakeholders. C Putchong, HITAP Newsletter 2008 1 3 8 9
13. Is Visual Inspection with Acetic Acid (VIA) appropriate for Cervical Cancer Screening: Randomized Controlled Trial with Crossover Design. K Tomyabatra, Bulletin of the Department of Medical Services 2007 32 31 8
14. Agendas Alternatives and Public Policy. J Kingdon, Boston: Little Brown 1984
15. Scaling up in international health: what are the key issues? LJ Mangham K Hanson, Health Policy Plan 2010 25 2 85 96 10.1093/heapol/czp066 20071454
16. Commentary: Managing scaling up: what are the key issues? L Gilson H Schneider, Health Policy Plan 2010 25 2 97 8 10.1093/heapol/czp067 20053734
17. Advocating for cervical cancer prevention. J Sherris I Argurto S Arrossi I Dzuba L Gaffikin C Herdman,, et al. Int J Gynecol Obstet 2005 89 Suppl 2 46 S54 10.1016/j.ijgo.2005.01.010 (Pubitemid 40488758)
18. Approval Letter - Gardasil. US FDA, 2006 http://www.fda.gov/ BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm165132.htm [cited 2009 March 3]
19. Cervical cancer - Ministry rejects use of vaccine. P Sarnsamak, High cost cited as main reason for decision 2007 http://www.nationmultimedia.com/ [cited 2009 March 15]
20. The MoPH provides free cervical cancer screening service throughout Thailand for 116 days, from mother's day to father's day, for 1 million women. The MoPH Information and Public Relations Office, The information and public relations office, Ministry of Public Health 2008
21. The uptake of the national program for cervical cancer screening. J Ngowsiri, The meeting of the Task Force to Develop a System for Cervical Cancer Screening Nonthaburi: National Health Security Office 2008
22. Advocacy, information and communicating: Engaging stakeholders at all levels to prepare for the introduction of HPV vaccines. K Fisher E Bass, Stop cervical cancer: Accelerating global access to HPV vaccines 2006 12th-13th December 2006; London; 2006.
23. World Cancer Declaration. International Union Against Cancer, 2008 http://www.uicc.org/templates/uicc/pdf/wcd2008/english.pdf accessed 2009 February 18]
24. Who should pay for HPV vaccine: the costiest vaccine to date? M Sipkoff, 2007 http://drugtopics.modernmedicine.com/drugtopics/Top+News/Who-should-pay- for-HPV-vaccine151the-costliest-vac/ArticleStandard/Article/detail/429591 [cited 2009 May 19]
25. Introducing HPV vaccine in developing countries - Key challenges and issues. J Agosti S Goldie, New England Journal of Medicine 2007 356 19 1908 10 10.1056/NEJMp078053 17494923
26. Preparing for the introduction of HPV vaccines. WHO, Policy and program guidance for countries. Geneva 2006
27. Human papillomavirus and HPV vaccines: Technical information for policy-makers and health professionals. WHO, Geneva: Department of Immunization, Vaccines and Biologicals 2007
28. Strategy to prevent cervical cancer: Report of a bi-regional consultation, April 11-13, 2007. WHO-SEARO, New Delhi: WHO Regional Office for South-East Asia 2007
29. HPV vaccines - New Tools in the Prevention of cervical cancer and other HPV disease in Asia and the Pacific. Family Health International, 2006 2nd November 2006; Bangkok; 2006
30. Health outcomes research: How can it assist decision-making for the prevention of cervical cancer and other HPV disease in Asia and the Pacific? Family Health International, 2008 12th February 2008; Bangkok; 2008
31. The Australian funding debate on quadrivalent HPV vaccine: A case study for the national pharmaceutical policy. E Roughead A Gilbert A Vitry, Health Policy 2008 88 2-3 250 7 10.1016/j.healthpol.2008.03.012 18468714
32. Joint statement on HPV vaccines and cervical cancer prevention. TGCS RTCOG, 2008 http://www.tgcsthai.com/images/stories/hpv%20vaccine-ca%20cervix.pdf [accessed 2009 March 3]
33. MoPH informed more than 8 millions women are at risk of cervical cancer and free Pap smear available throughout the country. Manager Online, 2008 http://www.manager.co.th/QOL/ViewNews.aspx?NewsID=9510000145215 [cited 2008 December 26]
34. Factors affecting the implementation of health legislation and its impact on the rural poor in China: A case study of implementation of the maternal and infant health care law in two poor counties. R Tolhurst T Zhang H Yang J Gao S Tang, Int J Health Plann Manage 2004 19 247 265 10.1002/hpm.761 15387091
35. The rise and resounding demise of Clinton Plan. T Skocpol, Health Affairs Spring 1995 66 85 10.1377/hlthaff.14.1.66 7657229
36. Expanding access to priority health interventions: a framework for understanding the constraints to scaling-up. K Hanson M Ransom V Oliveira-Cruz A Mills, Journal of International Development 2003 15 1 14 10.1002/jid.963 (Pubitemid 36175340)
37. Health sector reform and the interpretation of policy context. C Collins A Green D Hunter, Health Policy 1999 47 69 83 10.1016/S0168-8510(99)00003-2 10387811
38. Changing fortunes: analysis of fluctuating policy space for family planning in Kenya. J Crichton, Health Policy Plan 2008 23 339 350 10.1093/heapol/czn020 18653676
39. The SAZA study: implementing health financing reform in South Africa and Zambia. L Gilson J Doherty S Lake D McIntyre C Mwikisa S Thomas, Health Policy Plan 2003 18 1 31 46 10.1093/heapol/18.1.31 12582106
40. Kara Hanson, Susan Cleary, Helen Schneider, Sripen Tantivess and Lucy Gilson. Research 1472-6963 10 Suppl 1